What Celetrix does

Celetrix LLC is a privately held life-science tools company founded in 2012 and headquartered in Manassas, Virginia, that designs and manufactures electroporation instruments and consumables for biotech companies and academic research institutions. Its core technology is a patented sealed electroporation tube design that creates uniform electric fields and compresses gas bubbles, addressing the dead zones, arcing, and cytotoxicity problems of traditional cuvette and capillary systems. The product portfolio spans four mammalian cell electroporators (Model SP100, LE+, EX+, and the large-scale SLT), two ultra-high voltage systems for bacteria and yeast (UHV and UHV-Plus), an electrofusion accessory for hybridoma generation, and a specialized THP-1 Helper Kit for monocytic cell lines. The Model SLT can process 10ml or 2x10E9 CHO cells in a single reaction, positioning the company in industrial antibody production as well as research-scale transfection.

The platform targets four primary use-case segments: CAR-T, CAR-NK, and TCR-T cell therapy developers; biopharmaceutical manufacturers producing antibodies and recombinant proteins in CHO cells; CRISPR/genome editing researchers; and stem cell therapy developers working with iPSCs. Differentiated performance claims include >90% transfection efficiency in many mammalian cell types, >60% post-electroporation PBMC viability, 64-80% PBMC transfection with GFP plasmid, >73% iPSC efficiency with cells remaining undifferentiated, and >99% efficiency for small plasmids in CHO cells.

Celetrix monetizes through capital equipment sales (instruments) plus recurring consumables (tubes and buffer kits sized from 20ul to 10ml), supplemented by development services for biotech clients. Pricing is quote-based and not publicly disclosed. Distribution is entirely direct via the company website, email ([email protected]), and phone (1-646-801-1881), with no third-party distributors disclosed. The company also operates a Chinese-language site (celetrix.cn), indicating international market activity. The company is a participant in the NIH SBIR/STTR grant program and has 1-10 employees with no disclosed institutional venture capital.

Name

Celetrix

Legal name

Celetrix LLC

Website

https://celetrix.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Celetrix LLC develops patented sealed-tube electroporation instruments and consumables used by biotech firms and research labs for mammalian cell, bacteria, and yeast transfection in applications including CAR-T therapy development, antibody production, CRISPR gene editing, and stem cell engineering.

Ownership category

akta.pro rank

Product category

Laboratory Electroporation Equipment

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens) (HLAGAIAC)

Keywords

• Electroporation instruments
• Cell transfection equipment
• Lab electroporators
• Gene delivery systems
• Biotech research instruments

Headquarters

HQ city

Manassas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Electroporation Instruments: Sale of electroporation hardware including SP100 (basic, 20ul-100ul), LE+ (20ul-200ul), EX+ (20ul-1ml), and SLT (200ul-10ml) models. These are capital equipment purchases for laboratories and biotech companies.
2. Electroporation Kits and Consumables: Recurring sales of electroporation tubes and buffer kits in various sizes (20ul, 100ul, 120ul, 200ul, 400ul, 600ul, 1ml, 5ml, 10ml). Kits include 48 tubes for smaller sizes, 20 tubes for larger sizes. Universal buffer works for all mammalian cell types.
3. THP-1 Helper Kit: Specialized accessory kit (Catalog#:13-0201) for monocytic cell line electroporation applications requiring enhanced cell survival.
4. Bacterial/Yeast Electroporation: UHV and UHV-Plus systems for bacteria and yeast electroporation with dedicated kits. UHV-Plus can also electroporate mammalian cells in 20ul format.
5. Development Services: Celetrix provides development services to biotech companies and research institutions in addition to product sales, potentially as a professional services revenue stream.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Celetrix designs, manufactures, and sells electroporation instruments (SP100, LE+, EX+, SLT, UHV, UHV-Plus) and proprietary sealed-tube consumable kits used to deliver DNA, RNA, siRNA, and proteins into mammalian, bacterial, and yeast cells. The products serve biotech companies and research institutions performing gene editing, antibody production, CAR-T/CAR-NK cell therapy development, and stem cell engineering.

Product overview

Celetrix offers a portfolio of electroporation instruments and consumables for mammalian cell, bacteria, and yeast transfection. The core instruments include Model SP100 (basic, 20-100ul), Model LE+ (upgraded, 20-200ul with dual Cell Line/PBMC modes), Model EX+ (expanded capacity up to 1ml), and Model SLT (large-scale, 10ml/2×10^9 cells). For bacteria and yeast, UHV and UHV-Plus systems provide ultra-high voltage electroporation (2.5KV-15KV). Supporting consumables include universal mammalian cell kits (20ul-10ml), hybridoma fusion kits (400ul), bacterial/yeast electroporation kits, and the specialized THP-1 Helper Kit for monocytic cell lines. Applications span genome editing (CRISPR/Cas9), CAR-T/CAR-NK therapy development, antibody production, and stem cell therapy.

Differentiator

Problem solved

Functional benefit

Products and services

• Model SP100 Electroporator Basic cell electroporation system supporting 20ul and 100ul electroporation tubes with simplified single pulse operation and a voltage range of 200-1000V. Designed for laboratories needing entry-level mammalian cell transfection capability.
• Model LE+ Electroporator Advanced cell electroporation system with Cell Line Mode and PBMC Mode for optimized large plasmid electroporation. Supports 20ul, 100ul, and 200ul tubes with a voltage range of 200-1500V.
• Model EX+ Electroporator High-capacity electroporation system supporting up to 1ml tubes for large-scale transfection. Processes 2x10^8 CHO cells for 40ml Fed-batch culture and includes optional fusion accessories for hybridoma generation.
• Model SLT Large-Scale Electroporator Large-scale single-tube electroporation system capable of processing 10ml samples or 2x10^9 CHO cells in a single reaction. Supports 200ul, 1ml, 5ml, and 10ml tubes with electro cell fusion add-on available for hybridoma generation.
• UHV Transformer Electroporator Ultra High Voltage electroporation system specifically designed for bacteria and yeast transfection. Voltage range 2.5KV-15KV with pulse time adjustable in 1ms steps and truly no-arcing technology.
• UHV-Plus Electroporator Advanced ultra high voltage electroporator expanding beyond bacteria and yeast to support high-efficiency mammalian cell transfection in 20ul format with superior cell viability.
• Universal Mammalian Cell Electroporation Kit (20ul-200ul) Universal kit containing 48 sealed electroporation tubes and buffer. One buffer works for all mammalian cells. Optimized for high-efficiency gene editing, CRISPR, and stable pool development.
• Universal Mammalian Cell Fusion Kit (400ul) Specialized kit for high-efficiency hybridoma generation and monoclonal antibody development. Supplied with sealed fusion tubes and dedicated buffer.
• Stable Pool/Transient Electroporation Kit (600ul and 1000ul) Kits for stable pool construction and small-scale transient transfection. Optimized for maximum transfection efficiency and cell viability.
• Large-Scale Transient Expression Kit (5ml and 10ml) High-volume kits for antibody production and recombinant protein expression in suspension cells like CHO and HEK293.
• Bacterial Electroporation Kits Kits for bacterial electroporation containing 48 tubes with buffer. Available in 20ul, 100ul, and 600ul sizes.
• Yeast Electroporation Kits Kits for yeast display with 48 tubes and UHV buffer. Available in 20ul, 100ul, 200ul, and 1ml sizes. Chemically optimized for high-efficiency yeast transfection.
• THP-1 Electroporation Kit (THP-M1) Helper kit specifically designed for plasmid electroporation of monocytic cell lines THP-1 and U937. Enables cell survival and stable cell line generation where standard electroporation causes cell death.
• Development Services Celetrix provides custom development services to biotech companies and research institutions in addition to product sales, leveraging its electroporation technology expertise to support customer-specific applications and protocols.

Quantifiable outcome

• Jurkat cell transfection efficiency >90% with fast cell growth
• +8 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• MaxCyte: MaxCyte is the leading pure-play electroporation company for cell therapy and gene editing applications, offering flow electroporation systems (ExPERT) for both research and clinical/commercial cell engineering. Directly comparable product category and target customer base (CAR-T developers, biotech, academic researchers).
• BTX (Harvard Apparatus): BTX/Harvard Apparatus is a specialized electroporation and electrofusion instrument manufacturer serving academic and biotech research labs. Direct competitor offering cuvettes and specialty electrofusion products similar to Celetrix's portfolio.
• BEX Co. BEX Co. is a Japanese electroporation specialist offering the CUY21 series of electroporators used in molecular biology and cell engineering research. Direct comparable technology with focus on academic and biotech transfection applications.

Broad incumbents

• Thermo Fisher Scientific (Neon Transfection System): Thermo Fisher offers the Neon transfection system as part of its life sciences tools portfolio, serving research and biotech customers with capillary-based electroporation. Same end markets (gene editing, cell therapy research) but bundled within a much larger scientific instrument business.
• Bio-Rad Laboratories (Gene Pulser): Bio-Rad's Gene Pulser systems are an established legacy electroporation platform with deep academic and biotech installed base. Directly competes on core electroporation functionality as part of a broader life science research tools company.
• Lonza (Nucleofector): Lonza acquired the Nucleofector technology and is a global CDMO/bioprocess giant offering electroporation instruments as part of a much broader cell and gene therapy services portfolio. Overlapping capability in transfection but operates at a vastly larger scale across many product lines.
• Sartorius (Polyplus transfection): Sartorius acquired Polyplus-transfection, providing both reagent-based and electroporation-adjacent transfection solutions for cell and gene therapy bioprocess. Competes indirectly through alternative transfection modalities (chemical, plasmid DNA reagents) used by the same customer base.

Emerging players

• Nepa Gene: Nepa Gene specializes in electroporation instruments (NEPA21, NEPA G2) for in vivo and in vitro applications, including tissue-targeted gene delivery. Comparable technology targeting cell biology and gene editing researchers with specialty positioning in tissue electroporation.
• CytoPulse Sciences: CytoPulse Sciences develops flow electroporation technology for clinical and research cell therapy applications, including gene editing. Comparable technology targeting cell therapy developers with technology overlap in scalable electroporation.
• Mirus Bio: Mirus Bio develops transfection reagents (including the TransIT series) and Ingenio electroporation solutions for cell biology research. Competes with Celetrix in primary cell and difficult-to-transfect cell markets with both reagent and instrument offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCH97jVG3xFDKBkSljhELxXw
• Xx.com/celetrix_llc
• Facebookfacebook.com/celetrix
• LinkedInlinkedin.com/company/celetrix-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celetrix